Yoshihiro Shiomi

Z-360 Suppresses Tumor Growth in MIA PaCa-2-bearing Mice via Inhibition of Gastrin-induced Anti-Apoptotic Effects.

Takao Tanaka, Y. Hori, Kazumasa Kuki, 2017, Anticancer research.

Z‐505 hydrochloride ameliorates chemotherapy‐induced anorexia in rodents via activation of the ghrelin receptor, GHSR1a

M. Takei, Takao Tanaka, Y. Ohira, 2018, European journal of pharmacology.

A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice*

Kohjiro Ueki, Yoshichika Yoshioka, Takashi Kadowaki, 2015, The Journal of Biological Chemistry.

Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.

M. Takei, Takao Tanaka, Y. Ohira, 2017, European journal of pharmacology.

Z-505, an Oral Ghrelin Receptor Agonist, Attenuates Anorexia After Total Gastrectomy in Rats.

M. Takei, T. Uno, Takao Tanaka, 2019, The Journal of surgical research.

Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.

M. Takei, Takao Tanaka, Y. Ohira, 2017, European journal of pharmacology.